Semaglutide

Semaglutide is a GLP-1 receptor agonist that affects appetite, satiety, gastric emptying, and glucose-dependent insulin signaling. It is one of the most widely studied treatments for weight management and blood sugar control. In a real-world Mayo Clinic study, adults with overweight or obesity receiving once-weekly Semaglutide lost about 10.9% of their body weight on average at 6 months. At Bowery Clinic, Semaglutide is a clinician-guided metabolic treatment to help regulate appetite, reduce cravings, and support sustainable weight loss.

Semaglutide mimics the GLP-1 hormone your body releases after eating. It increases feelings of fullness, reduces appetite and cravings, slows gastric emptying, and improves glucose-dependent insulin release. In routine clinical care, adults with type 2 diabetes saw about a 1.2 percentage-point reduction in HbA1c at 6 months, and studies have also shown improvements in cardiometabolic markers such as triglycerides and cholesterol.

Semaglutide is one of the most widely studied weight-management treatments, used by millions of people with a well-established safety profile. The most common side effects are mild and digestive—such as nausea, constipation, or reduced appetite—and usually ease as your body adjusts. Your dose starts low and increases gradually to keep things comfortable. Before you begin, your clinician reviews your health history and medications to make sure Semaglutide is a good fit for you.

Semaglutide can begin affecting appetite and fullness within the first few weeks. Meaningful weight change is usually assessed over the first 4–12 weeks, with larger changes developing over 3–6 months. Because the dose is increased gradually, early weeks should be viewed as the beginning of the treatment response rather than the final result.

Bowery Clinic peptides are higher-strength and clinically dosed compared to most research facilities that use much lower concentrations. They are compounded by licensed 503A pharmacies with physician oversight and sterile quality standards, prioritizing real therapeutic outcomes over cheaper, unregulated research-grade products, and come fully prepared and ready for use — no mixing or reconstitution needed.

Yes. All pharmacies in our network are fully licensed in the states where they operate and comply with all state board of pharmacy regulations. Unlike many peptide clinics, we partner exclusively with FDA-registered U.S. pharmacies that undergo rigorous evaluation and compliance checks.

Every patient receives treatment plans developed and monitored by licensed providers. This includes safe titration of dosages and ongoing medical oversight tailored to individual needs.

Injections deliver the medication directly into your system. This makes the absorption more consistent and effective. Troches are small dissolvable lozenges that sit in your mouth until they melt, slowly releasing medication through the lining of your cheek or under your tongue.